Praxis Precision Medicines (PRAX) Earnings Date, Estimates & Call Transcripts $35.56 -0.44 (-1.23%) As of 01:41 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Praxis Precision Medicines Earnings Summary Upcoming Earnings DateMay. 12Before Market OpensEstimatedConsensus EPS (Feb. 28) -$2.76 Actual EPS (Feb. 28) -$2.94 Missed By -$0.18 Actual Revenue (Feb. 28) $7.48MPraxis Precision Medicines issued Q4 2024 earnings on February 28, 2025, reporting an EPS of -$2.94, which missed analysts' consensus estimates of -$2.76 by $0.18. Quarterly revenue was reported to be $7.48 million, above analyst estimates of $0.36 million. With a trailing EPS of -$10.27, Praxis Precision Medicines' earnings are expected to decrease next year, from ($10.22) to ($12.22) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Press Release (8-K) Annual Report (10-K)SEC FilingPRAX Upcoming EarningsPraxis Precision Medicines' Q1 2025 earnings is scheduled for Monday, May 12, 2025, with a conference call scheduled on Friday, May 9, 2025 at 12:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Praxis Precision Medicines Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Praxis Precision Medicines and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataPRAX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PRAX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Praxis Precision Medicines Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$3.18-$2.14-$2.66Q2 20252-$3.64-$2.29-$2.97Q3 20252-$4.15-$2.42-$3.29Q4 20252-$4.16-$2.60-$3.38FY 20258-$15.13-$9.45-$12.29Q1 20261-$4.39-$4.39-$4.39Q2 20261-$4.82-$4.82-$4.82Q3 20261-$4.89-$4.89-$4.89Q4 20261-$4.90-$4.90-$4.90FY 20264($19.00)($19.00)($19.00) Praxis Precision Medicines Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/12/2025(Estimated)--------2/28/2025Q4 2024-$2.76-$2.94 -$0.18-$2.94$0.36M$7.48M11/6/2024Q3 2024-$2.01-$2.75 -$0.74-$2.75$0.53M$0.30M8/13/2024Q2 2024-$2.38-$1.74+$0.64-$1.74$1.44M$0.36M5/13/2024Q1 2024-$2.01-$2.84 -$0.83-$2.84$2.75M$0.43M3/5/2024Q4 2023-$3.05-$2.97+$0.08-$2.97$0.30M$0.52M11/7/2023Q3 2023-$5.25-$2.70+$2.55-$0.18-$0.47M8/9/2023Q2 2023-$9.90-$7.35+$2.55-$0.49-$0.78M5/11/2023Q1 2023-$11.25-$10.65+$0.60-$0.71-$0.68M Praxis Precision Medicines Earnings - Frequently Asked Questions When is Praxis Precision Medicines's earnings date? Praxis Precision Medicines has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 12th, 2025 based off last year's report dates. Learn more on PRAX's earnings history. Did Praxis Precision Medicines beat their earnings estimates last quarter? In the previous quarter, Praxis Precision Medicines (NASDAQ:PRAX) missed the analysts' consensus estimate of ($2.76) by $0.18 with a reported earnings per share (EPS) of ($2.94). Learn more on analysts' earnings estimate vs. PRAX's actual earnings. How can I view Praxis Precision Medicines's earnings report? Praxis Precision Medicines's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Praxis Precision Medicines generate each year? Praxis Precision Medicines (NASDAQ:PRAX) has a recorded annual revenue of $8.55 million. How much profit does Praxis Precision Medicines generate each year? Praxis Precision Medicines (NASDAQ:PRAX) has a recorded net income of -$123.28 million. PRAX has generated -$10.27 earnings per share over the last four quarters. What is Praxis Precision Medicines's EPS forecast for next year? Praxis Precision Medicines's earnings are expected to decrease from ($10.22) per share to ($12.22) per share in the next year. More Earnings Resources from MarketBeat Related Companies Scholar Rock Earnings Protagonist Therapeutics Earnings Crinetics Pharmaceuticals Earnings SpringWorks Therapeutics Earnings Organon & Co. Earnings Catalyst Pharmaceuticals Earnings Viking Therapeutics Earnings Xenon Pharmaceuticals Earnings MoonLake Immunotherapeutics Earnings Alvotech Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alphabet Rebounds After Strong Earnings and Buyback AnnouncementMarkets Think Robinhood Earnings Could Send the Stock UpIs the Floor in for Lam Research After Bullish Earnings?Texas Instruments: Earnings Beat, Upbeat Guidance Fuel RecoveryMarket Anticipation Builds: Joby Stock Climbs Ahead of EarningsIs Intuitive Surgical a Buy After Volatile Reaction to Earnings?Seismic Shift at Intel: Massive Layoffs Precede Crucial Earnings This page (NASDAQ:PRAX) was last updated on 4/28/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored‘Wheels Are Falling Off’ the U.S. Stock MarketThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Praxis Precision Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Praxis Precision Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PRAX Stock Free PRAX Stock Alerts